Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum
Graefe's Archive for Clinical and Experimental Ophthalmology, 10/05/09
Ganssauge M et al. – Risk of NA–AION should be taken into consideration when deciding for intravitreal application of drugs including anti–vascular endothelial growth factors (VEGF) agents like bevacizumab (Avastin) in the treatment of retinal vascular diseases.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09
Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09
Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09
Today in Neuro-Ophthalmology...keeping you current
Receive free subspecialty "5-minute updates" via email
Surgical interventions for idiopathic intracranial hypertension
Current Opinion in Ophthalmology, 10/28/09
Headache and the eye
Current Opinion in Ophthalmology, 10/19/09
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves orbitopathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/02/09
Article Search
Sponsor


See Latest Articles


